Evolve BioSystems Inc. – Trademark Portfolio
Entity Type: 03
Evolve BioSystems Inc. owns a portfolio of 23 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as EVIVO, GLYCOGUARD, and INFINANT HEALTH. Of these, 8 are registered and 1 is pending. The portfolio spans 4 Nice Classification classes, led by Class 5 (Pharmaceuticals) and Class 42 (Computer & Scientific). Headquartered in Davis, CA.
2121 2nd Street, Suite B107
Davis, CA 95618
Showing of trademarks Trademarks
Trademark Classifications
Evolve BioSystems Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Evolve BioSystems Inc. have?
Evolve BioSystems Inc. has 23 U.S. trademarks filed with the USPTO. Of these, 8 registered, 1 pending, 11 abandoned, 3 cancelled.
What trademark classes does Evolve BioSystems Inc. file in?
Evolve BioSystems Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Evolve BioSystems Inc.'s most well-known trademarks?
Evolve BioSystems Inc.'s registered trademark portfolio includes well-known marks such as EVIVO, GLYCOGUARD, and INFINANT HEALTH. These are among 8 currently registered trademarks in the portfolio.
What is Evolve BioSystems Inc.'s trademark registration success rate?
Evolve BioSystems Inc. has a 36% trademark registration rate, with 8 out of 22 resolved applications resulting in successful registration. Currently, 1 application is pending review.